ICLR logo

ICON plc (ICLR)

$163.58

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on ICLR

Market cap

$12.52B

EPS

7.4

P/E ratio

55.1

Price to sales

1.48

Dividend yield

--

Beta

1.201

Price on ICLR

Previous close

$159.84

Today's open

$159.87

Day's range

$159.55 - $164.35

52 week range

$66.57 - $203.91

Profile about ICLR

CEO

Barry Balfe

Employees

39800

Headquarters

Dublin 18,

Exchange

Nasdaq Global Select

Shares outstanding

76567325

Issue type

American Depository Receipt

ICLR industries and sectors

Healthcare

Biotechnology & Life Sciences

News on ICLR

Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?

Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock?

news source

Zacks Investment Research • Aug 28, 2026

news preview

Oakmark Concentrated Strategy Q2 2026 Performance Review

The portfolio's return was 9.21% (net) for the reporting period. Centene, ICON and Keurig Dr Pepper were the contributors during the quarter. Intercontinental Exchange, Salesforce and ConocoPhillips were the detractors during the quarter.

news source

Seeking Alpha • Aug 11, 2026

news preview

Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?

ICLR's discounted valuation and $23.4B backlog support upside potential, but falling estimates, weaker margins and execution risks argue for patience.

news source

Zacks Investment Research • Aug 6, 2026

news preview

ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen

ICON's 33.2% rally is backed by stronger proposal flow, bookings and backlog, but weaker earnings and margins cloud the recovery.

news source

Zacks Investment Research • Aug 5, 2026

news preview

ICON Announces Private Offering of Notes

DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR) (“ICON”), a world-leading clinical research organization, announced today that its wholly-owned subsidiary, ICON Investments Six Designated Activity Company (the “Issuer”), intends to offer one or more series of senior notes (the “Notes”), in a private offering (the “Offering”) with registration rights, subject to market and other conditions. The Notes will be guaranteed on a senior unsecured basis by ICON.

news source

Business Wire • Aug 4, 2026

news preview

ICON Announces Results of Annual General Meeting

DUBLIN--(BUSINESS WIRE)--ICON Announces Results of Annual General Meeting.

news source

Business Wire • Jul 31, 2026

news preview

Icon Q2 Earnings Call Highlights

Icon NASDAQ: ICLR reported second-quarter 2026 revenue growth and strong bookings as higher pass-through activity supported the top line, while the company continued to manage business-mix pressures affecting reported margins.

news source

MarketBeat • Jul 30, 2026

news preview

ICON Public Limited Company (ICLR) Q2 2026 Earnings Call Transcript

ICON Public Limited Company (ICLR) Q2 2026 Earnings Call Transcript

news source

Seeking Alpha • Jul 30, 2026

news preview

ICON Reports Second Quarter 2026 Results

DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today reported its financial results for the second quarter ended June 30, 2026.

news source

Business Wire • Jul 29, 2026

news preview

Icon PLC (ICLR) Lags Q2 Earnings Estimates

Icon PLC (ICLR) came out with quarterly earnings of $2.56 per share, missing the Zacks Consensus Estimate of $2.57 per share. This compares to earnings of $3.26 per share a year ago.

news source

Zacks Investment Research • Jul 30, 2026

news preview

¹ Disclosures

Get started with M1

Invest in ICON plc

Open an M1 investment account to buy and sell ICON plc commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in ICLR on M1